23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Integra LifeSciences Holdings Corporation › 2025-2026

Integra LifeSciences Holdings Corporation 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Integra LifeSciences Holdings Corporation’s Form 8-K, filed May 8, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 10Reported items
  • 256Asset managers, any item
  • 2,835Fund votes
  • May 7, 2026Meeting date

Results at a glance

Meeting of May 7, 2026: 10 items on Integra LifeSciences Holdings Corporation’s Form 8-K, filed May 8, 2026: 7 elected · 3 approved.

Dissent

Notable dissent: 1 director (10.2% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Rubric Capital (13F, 9.5%, as of September 30, 2026)

Explore Integra LifeSciences Holdings Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Integra LifeSciences Holdings Corporation

These tallies are Integra LifeSciences Holdings Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 8, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Integra LifeSciences Holdings Corporation — official shareholder meeting results, meeting held May 7, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Keith Bradley, Ph.D. 64,904,3724,378,28833,540 --3,918,311 94%Elected—
Elect Director: Shaundra D. Clay 68,996,420286,93932,841 --3,918,311 99.6%Elected—
Elect Director: Stuart M. Essig, Ph.D. 68,172,6701,113,68829,842 --3,918,311 98%Elected—
Elect Director: Jeffrey A. Graves, Ph.D. 65,841,9173,442,84431,439 --3,918,311 95%Elected—
Elect Director: Barbara B. Hill 62,241,2037,042,47532,522 --3,918,311 90%Elected—
Elect Director: Renee W. Lo 68,619,639664,39032,171 --3,918,311 99.0%Elected—
Elect Director: Christian S. Schade 68,247,3571,037,01031,833 --3,918,311 99%Elected—
2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year 72,313,820863,17957,512 --0 99%Approved—
3. On an advisory, non-binding basis, the compensation of the Company's named executive officers 68,472,769732,580110,851 --3,918,311 99%Approved—
4. The Plan Amendment 68,005,4331,269,23141,536 --3,918,311 98%Approved—

Source: Integra LifeSciences Holdings Corporation, Form 8-K, filed with the SEC on May 8, 2026 — read the filing on EDGAR.

How asset managers voted at the Integra LifeSciences Holdings Corporation 2025-2026 meeting

256 asset managers disclosed a vote on at least one Integra LifeSciences Holdings Corporation item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Integra LifeSciences Holdings Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Stuart M. Essig, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 68,172,670AGAINST: 1,113,688

Prior year: 98.0% for (May 9, 2025 meeting) ▲ 0.4 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Stuart M. Essig

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Stuart M. Essig, Ph.D.”): 68,172,670 for, 1,113,688 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 31,509,261 for, 139,021 against, 20,489 abstained.

FOR
FOR: 31,509,261AGAINST: 139,021ABSTAIN: 20,489
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3879,193 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,27557 1,1590For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Jeffrey A. Graves, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 65,841,917AGAINST: 3,442,844

Prior year: 99.4% for (May 9, 2025 meeting) ▼ 4.3 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Jeffrey A. Graves

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Jeffrey A. Graves, Ph.D.”): 65,841,917 for, 3,442,844 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 31,597,614 for, 51,827 against, 19,330 abstained.

FOR
FOR: 31,597,614AGAINST: 51,827ABSTAIN: 19,330
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,027,56514 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street994,4920 00For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Barbara B. Hill

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%
FOR: 62,241,203AGAINST: 7,042,475

Prior year: 97.4% for (May 9, 2025 meeting) ▼ 7.6 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Barbara B. Hill

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Barbara B. Hill”): 62,241,203 for, 7,042,475 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 30,264,114 for, 1,384,168 against, 20,489 abstained.

FOR
FOR: 30,264,114AGAINST: 1,384,168ABSTAIN: 20,489
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,013,70313,877 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street2,345990,988 1,1590Against
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA0153,428 00Against
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Renee W. Lo

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 68,619,639AGAINST: 664,390

Prior year: 98.9% for (May 9, 2025 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Renee W. Lo

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Renee W. Lo”): 68,619,639 for, 664,390 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 31,650,070 for, 28,212 against, 20,489 abstained.

FOR
FOR: 31,650,070AGAINST: 28,212ABSTAIN: 20,489
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3889,192 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,3330 1,1590For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Christian S. Schade

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 68,247,357AGAINST: 1,037,010

Prior year: 97.8% for (May 9, 2025 meeting) ▲ 0.7 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Christian S. Schade

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Christian S. Schade”): 68,247,357 for, 1,037,010 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 31,650,012 for, 28,270 against, 20,489 abstained.

FOR
FOR: 31,650,012AGAINST: 28,270ABSTAIN: 20,489
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3879,193 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,27557 1,1590For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Keith Bradley, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 64,904,372AGAINST: 4,378,288

Prior year: 97.8% for (May 9, 2025 meeting) ▼ 4.1 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Keith Bradley

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Keith Bradley, Ph.D.”): 64,904,372 for, 4,378,288 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 31,403,038 for, 185,244 against, 20,489 abstained.

FOR
FOR: 31,403,038AGAINST: 185,244ABSTAIN: 20,489
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3749,206 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,27557 1,1590For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Shaundra D. Clay

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 68,996,420AGAINST: 286,939

Prior year: 99.7% for (May 9, 2025 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Shaundra D. Clay

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Shaundra D. Clay”): 68,996,420 for, 286,939 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 31,560,071 for, 28,211 against, 20,489 abstained.

FOR
FOR: 31,560,071AGAINST: 28,211ABSTAIN: 20,489
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3899,191 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,3330 1,1590For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity…

No official matchOTHER SOCIAL ISSUES

Combines 3 wordings of this item as funds reported it.

99.7% of fund votes cast · no official result

FOR
Details: description as filed, votes by 75 asset managers

Description as filed by funds: To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan.

The 75 asset managers below reported 31,546,011 for, 95,208 against, 19,330 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 31,546,011AGAINST: 95,208ABSTAIN: 19,330
Largest asset managers voting on “To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Eq” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,027,5763 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street994,43557 00For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 75 asset managers. All 75 are in the interactive database (link above).

On an advisory, non-binding basis, the compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 68,472,769AGAINST: 732,580

Prior year: 98.2% for (May 9, 2025 meeting) ▲ 0.8 pts

Details: description as filed, official tally, votes by 256 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of our named executive officers.

Integra LifeSciences Holdings Corporation’s own tally for this item (“3. On an advisory, non-binding basis, the compensation of the Company's named executive officers”): 68,472,769 for, 732,580 against — passed, per its Form 8-K filed May 8, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item No. 3: The stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers, by the votes set forth below.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 74 asset managers voting on “To approve, on a non-binding advisory basis, the compensation of our named executive officers.” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,027,5772 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street994,43557 00For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century0126,080 00Against
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Fund voting reports, all 74 managers: 31,447,699 for, 131,742 against, 81,330 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 201 asset managers voting on “To approve, on a non-binding advisory basis, the compensation of our named executive officers.” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Rubric Capital Management LP3,983,2600 00For
Invesco3,934,4080 00For
FULLER & THALER ASSET MANAGEMENT, INC.3,428,0120 00For
PARADIGM CAPITAL MANAGEMENT INC/NY3,199,8200 00For
BOSTON MANAGEMENT & RESEARCH2,741,3450 00For
BlackRock2,671,6940 00For
State Street2,268,76014,748 00For
Neuberger Berman1,651,0820 00For
Charles Schwab1,563,3110 00For
GEODE CAPITAL MANAGEMENT, LLC1,481,4360 00For
Wellington1,201,9330 00For
Invenomic Capital Management LP966,9580 00For
Vanguard631,6990 00For
Northern Trust560,4313,452 00For
SYSTEMATIC FINANCIAL MANAGEMENT LP531,6730 00For
CANADA PENSION PLAN INVESTMENT BOARD434,9000 00For
PRINCIPAL GLOBAL INVESTORS328,8420 00For
Leeward Investments, LLC - MA294,6450 00For
Goldman Sachs274,5580 00For
MELLON INVESTMENTS Corp264,8430 00For
Legal & General Investment Management Ltd0237,766 00Against
Eaton Vance225,2750 00For
PUBLIC SECTOR PENSION INVESTMENT BOARD219,9790 00For
PACIFIC INVESTMENT MANAGEMENT CO LLC219,7030 00For
Victory Capital198,2310 00For

Institutional-manager reports, all 201 managers: 36,511,984 for, 542,608 against. Showing the 25 largest; every one is in the interactive database (link above).

The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 72,313,820AGAINST: 863,179

Prior year: 98.7% for (May 9, 2025 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2026.

Integra LifeSciences Holdings Corporation’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year”): 72,313,820 for, 863,179 against — passed, per its Form 8-K filed May 8, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item No. 2: The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year, by the votes set forth below.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 31,622,552 for, 56,889 against, 19,330 abstained.

FOR
FOR: 31,622,552AGAINST: 56,889ABSTAIN: 19,330
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public account” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,022,9154,664 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street994,43557 00For
GLENMEDE FUND INC890,7220 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Largest Integra LifeSciences Holdings Corporation shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 77,796,903 shares outstanding at the time of that meeting.

Fund voting reports: top Integra LifeSciences Holdings Corporation shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 9.12%
2Vanguard 9.03%
3Invesco 4.47%
4UNDISCOVERED MANAGERS FUNDS 3.72%
5Charles Schwab 1.95%
6Fidelity 1.64%
7Dimensional 1.39%
8State Street 1.28%
9GLENMEDE FUND INC 1.14%
10PARADIGM FUNDS 0.91%
Institutional-manager reports: top Integra LifeSciences Holdings Corporation shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Rubric Capital Management LP 5.12%
2Invesco 5.06%
3FULLER & THALER ASSET MANAGEMENT, INC. 4.41%
4PARADIGM CAPITAL MANAGEMENT INC/NY 4.11%
5BOSTON MANAGEMENT & RESEARCH 3.52%
6BlackRock 3.43%
7State Street 2.94%
8Neuberger Berman 2.12%
9Charles Schwab 2.01%
10GEODE CAPITAL MANAGEMENT, LLC 1.90%

Reported Integra LifeSciences Holdings Corporation holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Integra LifeSciences Holdings Corporation holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock10,319,169 13.26%Form 13F, quarter ended March 31, 2026
Tru St Partnership LP and Provco Leasing Corporation8,515,930 10.95%Proxy statement (DEF 14A), proxy filed April 6, 2026
Rubric Capital Management LP7,353,934 9.45%Proxy statement (DEF 14A), proxy filed April 6, 2026
Vanguard Group7,210,624 9.27%Form 13F, quarter ended March 31, 2026
Morgan Stanley3,849,067 4.95%Form 13F, quarter ended March 31, 2026
Invesco3,485,603 4.48%Form 13F, quarter ended March 31, 2026
State Street2,886,556 3.71%Form 13F, quarter ended March 31, 2026
Dimensional Fund Advisors2,774,988 3.57%Form 13F, quarter ended March 31, 2026
Goldman Sachs1,876,750 2.41%Form 13F, quarter ended March 31, 2026
Stuart M. Essig, Ph.D.1,785,271 2.29%Proxy statement (DEF 14A), proxy filed April 6, 2026

Percentages above are of 77,796,903 shares outstanding, as reported by Integra LifeSciences Holdings Corporation on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Integra LifeSciences Holdings Corporation's shareholder meeting held May 7, 2026, in the 2025-2026 proxy season, 256 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,835 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of our named executive officers. — Integra LifeSciences Holdings Corporation's filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Integra LifeSciences Holdings Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 8, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Integra LifeSciences Holdings Corporation’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Integra LifeSciences Holdings Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Integra LifeSciences Holdings (IART) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/integra-lifesciences-holdings-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.